Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion type Assertion NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_head.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_provenance.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion evidence source_evidence_literature NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_provenance.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion SIO_000772 9253335 NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_provenance.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion wasDerivedFrom befree-2016 NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_provenance.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion wasGeneratedBy ECO_0000203 NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_provenance.